Education
About Us
Working with TipRanks
Follow Us
Dennis Matheis Insider Profile
4 Followers
Dennis Matheis, Director at DarioHealth, holds 665.44K shares in Lucid Diagnostics (Ticker: LUCD), holds 152.62K shares in DarioHealth (Ticker: DRIO). Most recently, Dennis Matheis Bought ― shares of Lucid Diagnostics on Aug 22, 2025 for an estimated value of $101.00K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+13.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dennis Matheis holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dennis Matheis
Dennis Matheis's Trading History
DarioHealth
Mar 08, 2024
Director
Uninformative Buy
―
$1.40M
Lucid Diagnostics
Aug 22, 2025
Director
Informative Buy
101.00K
$815.17K
List of latest transactions for each holding click on a transaction to see Dennis Matheis's performance on stock
You May Also Like
Dennis Matheis insider profile FAQ
What is the percentage of profitable transactions made by Dennis Matheis?
The percentage of profitable transactions made by Dennis Matheis is 100%.
What is the average return per transaction made by Dennis Matheis?
The average return per transaction made by Dennis Matheis is 13.70%.
What stocks does Dennis Matheis hold?
Dennis Matheis holds: DRIO, LUCD stocks.
What was Dennis Matheis’s latest transaction?
Dennis Matheis latest transaction was an Informative Buy of $101.00K.
What was Dennis Matheis's most profitable transaction?
Dennis Matheis’s most profitable transaction was an Informative Buy of LUCD stock on August 22, 2025. The return on the trade was 24.50%.
What is Dennis Matheis's role in DarioHealth?
Dennis Matheis's role in DarioHealth is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.